Next Fertility Spain

What Next Fertility Spain does

Next Fertility Spain is the Spanish operating arm of the Next Clinics Group, one of the largest assisted reproduction and clinical diagnostics groups in Europe. The company operates six fertility clinics across Spain (Valencia, Sevilla, Murcia, Huelva, Burgos, Vitoria) plus a clinic in Faro, Portugal, delivering a full portfolio of treatments including artificial insemination, IVF/ICSI, egg donation (ovodonación), the ROPA method for female same-sex couples, preimplantation genetic testing (PGT) and genetic compatibility testing (TCG), fertility preservation (vitrification), and gamete donation programs, supported by a facial biometric matching service and a dedicated emotional support unit. The company is the legal entity Nextclinics Spain, S.L.U., housing multiple wholly-owned operating subsidiaries (Instituto de Medicina Reproductiva, CEIFER Biobanco Sevilla, Next Fertility Murcia, Cegira Huelva, ART Vitoria, ART Burgos) and is vertically integrated through Gametia Biobank, one of Europe's most relevant gamete banks.

The technology stack is anchored by advanced embryology laboratory tools: vitrification for ultra-rapid cryopreservation, Time-Lapse embryo monitoring for non-invasive developmental assessment, and the RI Witness sample identification and chain-of-custody system. Preimplantation genetic testing is performed using next-generation sequencing (NGS) technology, and a facial biometric analysis module is offered as an adjunct donor-matching service. The company positions itself around fixed, transparent per-treatment pricing with no hidden fees, interest-free patient financing up to 36 months, no waitlists, and a six-language patient services capability. Group-level scale (20 clinics, 8 laboratories, 9 European countries) and over 20 years of operational experience form the basis of its competitive positioning.

The business model is B2C consumer healthcare with revenue generated on a per-treatment basis from individual patients (heterosexual couples, female same-sex couples, single mothers by choice, women seeking fertility preservation, and oncology patients). Customers are acquired through a digital-first go-to-market (SEO-optimized website, blog content marketing, organic social on LinkedIn/Instagram/Facebook/YouTube, and online appointment booking for a free first visit) with local sports sponsorships (Deportivo Alavés, Baskonia) supporting brand awareness. Revenue streams are one-time per treatment cycle, supplemented by interest-bearing financing receivables on patient payment plans. The company has not disclosed funding rounds, revenue, or specific cycle volumes; corporate ownership rests with the Next Clinics Group rather than financial sponsors.

Name

Next Fertility Spain

Legal name

Nextclinics Spain, S.L.U.

Website

https://nextfertility.es

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Next Fertility Spain is the Spanish arm of the Next Clinics Group, operating six fertility clinics across Spain plus one in Portugal that deliver IVF, ICSI, egg donation, ROPA, PGT, and fertility preservation services to individuals and couples, supported by the Gametia Biobank and a six-language patient services team.

Ownership category

akta.pro rank

Product category

Reproductive Medicine and Fertility Services

NAICS

Family Planning Centers (621410)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industry

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC)

Keywords

• Assisted reproduction services
• Fertility treatments
• In vitro fertilization
• Fertility preservation
• Preimplantation genetic testing

Headquarters

HQ city

Valencia

HQ country

Spain

HQ region

Europe

Offices8 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Fertility Treatment Services: Revenue generated from providing assisted reproduction treatments including artificial insemination, IVF/ICSI, egg donation (ovodonación), and the ROPA method. The company operates on a per-treatment basis with fixed, transparent pricing inclusive of all necessary techniques without extra charges.
2. Fertility Preservation Services: Egg and sperm cryopreservation (vitrification) services for women who wish to postpone motherhood or preserve fertility before medical treatments such as chemotherapy or radiotherapy.
3. Genetic Testing Services: Preimplantation genetic testing (PGT) and genetic compatibility testing (TCG) offered as part of fertility treatment protocols or as standalone services.
4. Financing Plans: The company offers financing options up to 36 months with no interest charges, making treatments accessible to a broader patient base.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Next Fertility Spain operates a network of fertility clinics offering assisted reproduction treatments including artificial insemination, IVF/ICSI, egg donation (ovodonación), and the ROPA method for female couples. It complements these treatments with preimplantation genetic testing (PGT), genetic compatibility testing (TCG), fertility preservation through vitrification, gamete donation programs, facial biometric analysis, and a psychological/emotional support unit, delivered across six clinic locations in Spain.

Product overview

Next Fertility Spain is part of the Next Clinics international group, offering a comprehensive portfolio of assisted reproduction treatments and services across six clinic locations in Spain (Sevilla, Valencia, Murcia, Huelva, Burgos, and Vitoria). The core treatments include Inseminación Artificial (Artificial Insemination), In Vitro (FIV)/ICSI, Ovodonación (Egg Donation), and Método ROPA (shared motherhood for female couples). Supporting services encompass genetic testing (PGT and TCG), fertility preservation, gamete donation, facial biometric analysis, and psychological support. The clinics employ advanced technologies including Vitrificación (vitrification), Time Lapse embryo monitoring, and RI Witness identification systems. The group also operates Gametia Biobank, one of Europe's most relevant gamete banks, and provides digital tools such as pregnancy week calculators, ovulation calculators, and IVF due date calculators. The company is part of a larger European network of 20 clinics and 8 laboratories across 9 countries with over two decades of experience.

Differentiator

Problem solved

Functional benefit

Products and services

• Inseminación Artificial (Artificial Insemination) Artificial insemination treatment that deposits semen (from partner or donor) into the uterus, including prior ovarian stimulation and sperm selection in the laboratory, for individuals and couples seeking a less invasive fertility treatment.
• In Vitro (FIV) / ICSI In vitro fertilization with ICSI (Intracytoplasmic Sperm Injection), where embryologists select individual sperm and inject them directly into each egg for fertilization in the laboratory, followed by embryo culture and transfer.
• Ovodonación (Egg Donation) In vitro fertilization using donated eggs from the Gametia Biobank; fertilized embryos are cultured and transferred to the recipient's uterus, for patients with low ovarian reserve or poor egg quality.
• Método ROPA (Reception of Oocytes from Partner) Treatment enabling female couples to share motherhood, with one partner providing the eggs and the other carrying the pregnancy, providing shared biological participation in conception.
• Test Genético Preimplantacional (PGT) Preimplantation genetic testing that analyzes embryo chromosomes before transfer using NGS technology, detecting aneuploidies and mosaic embryos to support embryo selection.
• Test de Compatibilidad Genética (TCG) Genetic compatibility testing to identify potential hereditary diseases when using donor gametes, ensuring maximum genetic safety for the resulting pregnancy.
• Preservación de la fertilidad (Fertility Preservation) Fertility preservation through egg, sperm, or embryo vitrification for women wishing to postpone motherhood or for patients facing medical treatments such as chemotherapy or radiotherapy that may compromise fertility.
• Donar óvulos (Egg Donation Program) Egg donation program with comprehensive medical, genetic, and psychological screening of donors supplying gametes to the Gametia Biobank for use in recipient treatments.
• Donar semen (Sperm Donation Program) Sperm donation program for healthy donors providing donor semen for use in fertility treatments such as artificial insemination or IVF/ICSI.
• Análisis biométrico facial (Facial Biometric Analysis) Facial biometric analysis service used for donor-recipient phenotypic matching or identification in fertility treatments involving donor gametes.
• Unidad de Apoyo Emocional (Emotional Support Unit) Psychological and emotional support unit providing counseling throughout the fertility treatment journey for patients and couples.

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Gametia BiobankcoreStrategic or Co-development PartnerGametia Biobank is described as one of the most relevant biobanks in Europe, operated by Next Fertility group. It is recognizable for its seriousness, reliability, and security in recruiting donors and obtaining gametes for treatments, using the latest technologies and knowledge available. The quality commitment extends to the biobank as part of Next Fertility's quality assurance system.
• Deportivo AlavésminorGTM or Marketing PartnerNext Fertility is an official collaborator/sponsor of Deportivo Alavés sports club, supporting the team as part of its community engagement and marketing activities.
• BaskoniaminorGTM or Marketing PartnerNext Fertility is an official collaborator/sponsor of Baskonia basketball club, supporting the team as part of its community engagement and marketing activities.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• CREATE Fertility: UK-based fertility chain operating multiple clinics with IVF, ICSI, and donor programs; a direct comparable to Next Fertility in adjacent geographies under the same parent group footprint.
• Ginefiv: Madrid-headquartered fertility clinic founded in 1987 offering artificial insemination, IVF, ICSI, egg donation, and PGD - a closely comparable Spanish operator with overlapping positioning on transparency and pricing.
• TFP (The Fertility Partnership): European fertility chain with clinics across the UK, Netherlands, and Germany offering IVF, ICSI, and donor gamete programs; closely comparable as a multi-country clinic group serving similar international patients.
• IVI-RMA Global: The largest European fertility group, formed from Spain's IVI and US-based RMA, offering a near-identical service portfolio (IVF/ICSI, egg donation, PGT, fertility preservation) and the dominant competitor across Spanish and broader European markets.
• Dexeus Mujer: Barcelona women's health provider with a large reproductive medicine unit covering IVF/ICSI, egg donation, fertility preservation, and gynecologic care - a comparable integrated women's health + fertility offering in Spain.
• Bourn Hall Clinic: Historic UK IVF pioneer with multiple clinic locations offering a comprehensive assisted reproduction portfolio and a comparable long-standing brand reputation for fertility outcomes.
• Clinica Tambre: Long-established Madrid-based fertility clinic offering IVF/ICSI, egg donation, and fertility preservation with a comparable service mix and Spanish patient base to Next Fertility Spain.
• Institut Marquès: Barcelona-based fertility clinic with strong international patient flow, offering IVF, ICSI, egg donation, and preimplantation genetic diagnosis - a direct competitor particularly in Catalonia and inbound medical tourism.
• Eugin: European fertility chain (now consolidated under IVI-RMA) operating across Spain, Italy, Denmark, and Latin America with comparable IVF/ICSI, donor gamete, and international patient services competing directly with Next Fertility.

Broad incumbents

• Genea: Australian-origin global fertility group with operations across Australia, Europe, and Asia, offering comparable assisted reproduction services and embryology technology at a broader international scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@nextfertilityspain
• Facebookfacebook.com/nextfertilityspain
• LinkedInlinkedin.com/company/nextfertilityspain
• Instagraminstagram.com/nextfertilityspain/?hl=es

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Next Fertility Spain